NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 323 filers reported holding NATERA INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,039 | -12.8% | 113,878 | -4.1% | 0.01% | -15.4% |
| Q2 2023 | $5,779 | -11.2% | 118,771 | +1.3% | 0.01% | -13.3% |
| Q1 2023 | $6,506 | +20.2% | 117,199 | -13.0% | 0.02% | +7.1% |
| Q4 2022 | $5,413 | -99.9% | 134,743 | +40.2% | 0.01% | +7.7% |
| Q3 2022 | $4,211,000 | +4.0% | 96,106 | -15.9% | 0.01% | +18.2% |
| Q2 2022 | $4,048,000 | -12.1% | 114,216 | +0.8% | 0.01% | +10.0% |
| Q1 2022 | $4,607,000 | -57.0% | 113,254 | -1.3% | 0.01% | -60.0% |
| Q4 2021 | $10,720,000 | -18.0% | 114,786 | -2.2% | 0.02% | -24.2% |
| Q3 2021 | $13,077,000 | – | 117,348 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |